New research reveals PD-L1 expression enhances survival in advanced ovarian cancer, linking it to homologous recombination ...

The T.E.A.L. (Tell Every Amazing Lady) walk/run in Prospect Park started 17 years ago, but this year, the nonprofit is ...

Genetic testing revealed that she was positive for BRCA1, a genetic mutation that increases one’s risk of breast and ovarian ...

Former marathon runner Paula Radcliffe revealed she and her husband Gary Lough initially dismissed the early signs of ovarian ...

Disease-free and overall survival were comparable between paclitaxel- and cisplatin-based heated chemotherapy regimens in ...

As a Northampton woman living with ovarian cancer, I wasn’t fortunate enough to benefit from early detection. Years ago, my ...

US ovarian cancer mortality rates declined from 1999 to 2020, but significant disparities remain across age, race, and geographic regions, highlighting the need for targeted public health efforts.

The hunt for a medical breakthrough has been caught up in the Trump administration's political assault on the university.

Researchers identify PPP2R1A gene mutations as a new marker linked to better immunotherapy response and survival in ovarian ...

A pairing of two experimental drugs inhibits tumor growth and blocks drug-induced resistance in ovarian cancer, according to ...

Fat tissue secretes hormones known as adipokines. Patients with obesity have a larger amount of leptin than a normal ...

New PICCOLO trial analyses showed that mirvetuximab soravtansine achieved 52% response rates and 27-month overall survival in ...